Pay in 4 interest-free payments of $30.50 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
Each library contains 2 or 5 mg of listed compounds in that category in separated vials in DMSO at the concentration of 10 mM or in solid format
H2O/c1-45(2)35-60(72(107)92-59(16-9-10-33-87-46(3)4)80(115)101-34-12-17-68(101)79(114)88-47(5)70(84)105)93-74(109)63(38-51-23-30-58(31-24-51)91-81(85)116)95-76(111)64(39-50-21-28-57(29-22-50)90-71(106)66-42-69(104)100-82(117)99-66)97-78(113)67(44-102)98-77(112)65(41-53-13-11-32-86-43-53)96-75(110)62(37-49-19-26-56(83)27-20-49)94-73(108)61(89-48(6)103)40-52-18-25-54-14-7-8-15-55(54)36-52
Formula: C30H34N8
A fluorescence-based high-throughput assay to identify inhibitors of Tyrosylprotein sulfotransferase activity
Treatment with SCR130 leads to inhibition of endogenous NHEJ
H3 receptor antagonist 1 Thrombospondin (TSP-1) (TFA) Each library contains 2 orH3 receptor antagonist 1 is an antagonist of histamine H3 receptor, used in the research of neurological disease. H3 receptor antagonist 1 is an antagonist of histamine H3 receptor, used in the research of neurological disease, such as depression, mood disorders, schizophrenia, anxiety disorders, Alzheimer's disease and attention deficit hyperactivity disorder. . WAGER, Travis, T., et al. HISTAMINE 3 RECEPTOR ANTAGONISTS. WO 2007049123 A1. Product
US$ 5250.00
US$ 450.00
US$ 28.00